Fig. 1From: Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cellsEffect of catalpol on the viability of human induced pluripotent stem cells with aconitine-induced cardiac arrhythmia. Catalpol supplementation increased cell viability by 7.5, 27.3, and 65.8% at 1, 10, and 100 µM concentrations, respectively. ***P < 0.001 vs. Group I; #P < 0.05 and ##P < 0.01 vs. Group IIBack to article page